Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults [clinicaltrials:NCT00051454]

Bio2RDF uri

Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults [clinicaltrials:NCT00051454]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT00051454

Bio2RDF identifier

NCT00051454

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00051454

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00051454

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:4c3cb4f1b6774aae040152e2cdb4237b

brief summary [clinicaltrials_vocabulary:brief-summary]

This study will examine ...... e vaccine or a placebo.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Safety and adverse events among the two vaccination groups [clinicaltrials_resource:4a2e2046447ec42d151cd42e0f9701a3]

Safety and adverse events among the two vaccination groups [clinicaltrials_resource:a87a2f8d298ee8b003b7f860ced85573]

Safety and adverse events among the two vaccination groups [clinicaltrials_resource:f91fc98df8988caea895b061179ec8b1]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Safety and adverse events among the two vaccination groups [clinicaltrials_resource:1018a29babceaa0ff97de9413e382763]

Safety and adverse events among the two vaccination groups [clinicaltrials_resource:245a189cb1787fe86203219a9ad105b1]

Safety and adverse events among the two vaccination groups [clinicaltrials_resource:908942dfa1716d34bf9eaf74132d266c]

Safety and adverse events among the two vaccination groups [clinicaltrials_resource:a15370a9b9bf0c3f23799c5dce779f02]

Safety and adverse events among the two vaccination groups [clinicaltrials_resource:a6754f95d91de6186add9a3566a88d2f]

Safety and adverse events among the two vaccination groups [clinicaltrials_resource:dd7d2aad5484b4c7d72f1ff19b701e46]

completion date [clinicaltrials_vocabulary:completion-date]

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

condition [clinicaltrials_vocabulary:condition]

HIV Infections [clinicaltrials_resource:3f980d9baec1b9b18d5a0f38f4921607]

country [clinicaltrials_vocabulary:country]

Australia [clinicaltrials_resource:4442e4af0916f53a07fb8ca9a49b98ed]

detailed description [clinicaltrials_vocabulary:detailed-description]

The purpose of this stu ...... ll continue to Week 52.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00051454 [clinicaltrials_resource:6278a56a9e86c09a79f79cff36fd75f9]

enrollment [clinicaltrials_vocabulary:enrollment]

http://www.w3.org/2001/XMLSchema#integer

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2003-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

HIV DNA plasmid vaccine plus recombinant fowlpox vector [clinicaltrials_resource:abba1671fca392f8ccde78f5d53f90ff]

keyword [clinicaltrials_vocabulary:keyword]

HIV Preventive Vaccine

http://www.w3.org/2001/XMLSchema#string

HIV Seronegativity

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2007-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

nct id [clinicaltrials_vocabulary:nct-id]

NCT00051454

http://www.w3.org/2001/XMLSchema#string

official title [clinicaltrials_vocabulary:official-title]

A Randomised, Placebo-Controll ...... Boost HIV Vaccination Strategy

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

N01-AI05395

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

David A Cooper, MD, DSc [clinicaltrials_resource:70e0fcddf9b1b2e371a3424b3a6b612e]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

United States: Federal Government [clinicaltrials_resource:15a952dd0198445f4ddd5909936bc0e7]

phase [clinicaltrials_vocabulary:phase]

Phase 1/Phase 2 [clinicaltrials_resource:72d8d9eabd48f679d5dffa41c4dd93f7]

source [clinicaltrials_vocabulary:source]

National Institute of Allergy and Infectious Diseases (NIAID) [clinicaltrials_resource:d9a74aeb9c0d0448f38e08189395de72]

start date [clinicaltrials_vocabulary:start-date]

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00051454 study design [clinicaltrials_resource:2986e785755fca9fecc5a0775cdd2983]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00051454

verification date [clinicaltrials_vocabulary:verification-date]

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00051454

http://www.w3.org/2001/XMLSchema#string

title

Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Evaluation of the Safety of an ...... s [clinicaltrials:NCT00051454]

@en